Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors

Assay and Drug Development Technologies

Volumn 12, Issue 4, 2014, Pages 207-218

  Edmondson, Rasheena ^a   Broglie, Jessica Jenkins ^a   Adcock, Audrey F ^a   Yang, Liju ^a  

^a NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CELL RECEPTOR;

BIOSENSOR; CELL CULTURE; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CYTOTOXICITY TEST; DRUG DEVELOPMENT; GENE EXPRESSION; HUMAN; MONOLAYER CULTURE; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SPHEROID CELL; THREE DIMENSIONAL CELL CULTURE; TWO DIMENSIONAL CELL CULTURE; ANIMAL; CULTURE TECHNIQUE; GENETIC PROCEDURES; PROCEDURES;

ANIMALS; BIOSENSING TECHNIQUES; CELL CULTURE TECHNIQUES; CELLS, CULTURED; DRUG DISCOVERY; HUMANS;

EID: 84901014044     PISSN: 1540658X     EISSN: 15578127     Source Type: Journal    
DOI: 10.1089/adt.2014.573     Document Type: Review

References (97)

1. Birgersdotter A, Sandberg R, Ernberg I: Gene expression perturbation in vitro-a growing case for three-dimensional (3D) culture systems. Semin Cancer Biol 2005;15:405-412.
2. Weaver VM, Petersen OW, Wang F, et al.: Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 1997;137:231-245.
3. Bhadriraju K, Chen CS: Engineering cellular microenvironments to improve cell-based drug testing. Drug Discov Today 2002;7:612-620.
4. DiMasi JA, Grabowski HG: Economics of new oncology drug development. J Clin Oncol 2007;25:209-216.
5. Breslin S, O'Driscoll L: Three-dimensional cell culture: the missing link in drug discovery. Drug Discov Today 2013;18:240-249.
6. Hopkins AL: Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol 2008;4:682-690.
7. Kola I: The state of innovation in drug development. Clin Pharmacol Ther 2008;83:227-230.
8. Baharvand H, Hashemi SM, Kazemi Ashtiani S, Farrokhi A: Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro. Int J Dev Biol 2006;50:645-652.
9. Benya PD, Shaffer JD: Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 1982;30:215-224.
10. Nelson CM, Bissell MJ: Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. Semin Cancer Bio. 2005;15:342-352.
11. Shield K, Ackland ML, Ahmed N, Rice GE: Multicellular spheroids in ovarian cancer metastases: biology and pathology. Gynecol Oncol 2009;113:143-148.
12. Zietarska M, Maugard CM, Filali-Mouhim A, et al.: Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC). Mol Carcinog 2007;46:872-885.
13. Lee J, Cuddihy MJ, Kotov NA: Three-dimensional cell culture matrices: state of the art. Tissue Eng Part B Rev 2008;14:61-86.
14. Justice BA, Badr NA, Felder RA: 3D cell culture opens new dimensions in cell-based assays. Drug Discov Today 2009;14:102-107.
15. Reininger-Mack A, Thielecke H, Robitzki AA: 3D-biohybrid systems: applications in drug screening. Trends Biotechnol 2002;20:56-61.
16. Sun T, Jackson S, Haycock JW, MacNeil S: Culture of skin cells in 3D rather than 2D improves their ability to survive exposure to cytotoxic agents. J Biotechnol 2006;122:372-381.
17. Gurski L, Petrelli N, Jia X, Farach-Carson M: Three-dimensional matrices for anti-cancer drug testing and development. Oncol Issues 2010;25:20-25.
18. Tibbitt MW, Anseth KS: Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng 2009;103:655-663.
19. Rimann M, Graf-Hausner U: Synthetic 3D multicellular systems for drug development. Curr Opin Biotechnol 2012;23:803-809.
20. Huang H, Ding Y, Sun XS, Nguyen TA: Peptide hydrogelation and cell encapsulation for 3D culture of MCF-7 breast cancer cells. PLoS One 2013; 8:e59482.
21. Huh D, Hamilton GA, Ingber DE: From 3D cell culture to organs-on-chips. Trends Cell Biol 2011;21:745-754.
22. Kim D-H, Provenzano PP, Smith CL, Levchenko A: Matrix nanotopography as a regulator of cell function. J Cell Biol 2012;197:351-360.
23. Chen W, Villa-Diaz LG, Sun Y, et al.: Nanotopography influences adhesion, spreading, and self-renewal of human embryonic stem cells. ACS Nano 2012; 6:4094-4103.
24. Kim JB: Three-dimensional tissue culture models in cancer biology. Semin Cancer Biol 2005;15:365-377.
25. Khaitan D, Chandna S, Arya MB, Dwarakanath BS: Establishment and characterization of multicellular spheroids from a human glioma cell line; Implications for tumor therapy. J Transl Med 2006;4:1-13.
26. Mehta G, Hsiao AY, Ingram M, Luker GD, Takayama S: Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. J Control Release 2012;164:192-204.
27. Chitcholtan K, Sykes P, Evans J: The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer. J Transl Med 2012;10:1-16.
28. Fallica B, Maffei JS, Villa S, Makin G, Zaman M: Alteration of cellular behavior and response to PI3K pathway inhibition by culture in 3D collagen gels. PLoS One 2012;7:e48024.
29. Luca AC, Mersch S, Deenen R, et al.: Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines. PLoS One 2013;8:e59689.
30. Wong S, El-Gamal A, Griffin P, Nishi Y, Pease F, Plummer J: Monolithic 3D integrated circuits. Paper presented at VLSI Technology, Systems and Applications 2007 (VLSI-TSA 2007), Hsinchu, Taiwan, April 23-25, 2007.
31. Maria OM, Maria O, Liu Y, Komarova SV, Tran SD: Matrigel improves functional properties of human submandibular salivary gland cell line. Int J Biochem Cell Biol 2011;43:622-631.
32. Wang X, Sun L, Maffini MV, Soto A, Sonnenschein C, Kaplan DL: A complex 3D human tissue culture system based on mammary stromal cells and silk scaffolds for modeling breast morphogenesis and function. Biomaterials 2010;31:3920-3929.
33. Hongisto V, Jernstrom S, Fey V, et al.: High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells. PLoS One 2013;8:e77232.
34. Gurski LA, Jha AK, Zhang C, Jia X, Farach-Carson MC: Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells. Biomaterials 2009;30:6076-6085.
35. Kenny PA, Lee GY, Myers CA, et al.: The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol 2007;1:84-96.
36. Sodunke TR, Turner KK, Caldwell SA, McBride KW, Reginato MJ, Noh HM: Micropatterns of Matrigel for three-dimensional epithelial cultures. Biomaterials 2007;28:4006-4016.
37. Chitcholtan K, Asselin E, Parent S, Sykes PH, Evans JJ: Differences in growth properties of endometrial cancer in three dimensional (3D) culture and 2D cell monolayer. Exper Cell Res 2013;319:75-87.
38. Härmä V, Virtanen J, Mäkelä R, et al.: A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PLoS One 2010;5:e10431.
39. Lin RZ, Chang HY: Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol J 2008;3:1172-1184.
40. Price KJ, Tsykin A, Giles KM, et al.: Matrigel basement membrane matrix influences expression of microRNAs in cancer cell lines. Biochem Biophys Res Commun 2012;427:343-348.
41. Loessner D, Stok KS, Lutolf MP, Hutmacher DW, Clements JA, Rizzi SC: Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials 2010;31:8494-8506.
42. Kiss DL, Windus LCE, Avery VM: Chemokine receptor expression on integrin-mediated stellate projections of prostate cancer cells in 3D culture. Cytokine 2013;64:122-130.
43. Li H, Fan X, Houghton J: Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem 2007;101:805-815.
44. Pageau SC, Sazonova OV, Wong JY, Soto AM, Sonnenschein C: The effect of stromal components on the modulation of the phenotype of human bronchial epithelial cells in 3D culture. Biomaterials 2011;32:7169-7180.
45. Shen FH, Werner BC, Liang H, et al.: Implications of adipose-derived stromal cells in a 3D culture system for osteogenic differentiation: an in vitro and in vivo investigation. Spine J 2013;13:32-43.
46. Matsuda N, Shimizu T, Yamato M, Okano T: Tissue engineering based on cell sheet technology. Adv Mater 2007;19:3089-3099.
47. Kawaguchi N, Hatta K, Nakanishi T: 3D-culture system for heart regeneration and cardiac medicine. Biomed Res Int 2013;2013:895967.
48. Tsuda Y, Kikuchi A, Yamato M, Chen G, Okano T: Heterotypic cell interactions on a dually patterned surface. Biochem Biophys Res Commun 2006;348:937-944.
49. Harimoto M, Yamato M, Hirose M, et al.: Novel approach for achieving double-layered cell sheets co-culture: overlaying endothelial cell sheets onto monolayer hepatocytes utilizing temperature-responsive culture dishes. J Biomed Mater Res 2002;62:464-470.
50. Baker BM, Chen CS: Deconstructing the third dimension-how 3D culture microenvironments alter cellular cues. J Cell Sci 2012;125:3015-3024.
51. Xu X, Gurski LA, Zhang C, Harrington DA, Farach-Carson MC, Jia X: Recreating the tumor microenvironment in a bilayer, hyaluronic acid hydrogel construct for the growth of prostate cancer spheroids. Biomaterials 2012;33:9049-9060.
52. Yip D, Cho CH: A multicellular 3D heterospheroid model of liver tumor and stromal cells in collagen gel for anti-cancer drug testing. Biochem Biophys Res Commun 2013;433:327-332.
53. Trédan O, Galmarini CM, Patel K, Tannock IF: Drug resistance and the solid tumor microenvironment. J Nat Cancer Inst 2007;99:1441-1454.
54. Szot CS, Buchanan CF, Freeman JW, Rylander MN: 3D in vitro bioengineered tumors based on collagen I hydrogels. Biomaterials 2011;32:7905-7912.
55. DiMasi JA, Hansen RW, Grabowski HG: The price of innovation: new estimates of drug development costs. J Health Econ 2003;22:151-185.
56. Karlsson H, Fryknäs M, Larsson R, Nygren P: Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system. Exper Cell Res 2012;318:1577-1585.
57. Walker DM, Boey G, McDonald LA: The pathology of oral cancer. Pathology 2003;35:376-383.
58. Sodek KL, Ringuette MJ, Brown TJ: Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype. Int J Cancer 2009;124:2060-2070.
59. News GEaB. Top 10 Clinical Trial Failures of 2013. www.genengnews.com/ insight-and-intelligenceand153/top-10-clinical-trial-failures-of-2013/77900029/? page = 1 (last accessed on February 3, 2014).
60. Hingorani P, Zhang W, Piperdi S, et al.: Preclinical activity of palifosfamide lysine (ZIO-201) in pediatric sarcomas including oxazaphosphorine-resistant osteosarcoma. Cancer Chemother Pharmacol 2009;64:733-740.
61. Genmab. Zalutumumab. www.genmab.com/partnering/licensing-opportunities/ products (last accessed on April 7, 2014).
62. Ivaska J, Nevo J: Assessing risk of metastases and/or ddfs of patients with neoplasms, screening of patients responding to cancer therapy and such therapy. WO Patent App. PCT/FI2009/050, 555. December 30, 2009.
63. Wen Z, Liao Q, Hu Y, You L, Zhou L, Zhao Y: A spheroid-based 3-D culture model for pancreatic cancer drug testing, using the acid phosphatase assay. Braz J Med Biol Res 2013;46:634-642.
64. Tung Y-C, Hsiao AY, Allen SG, Torisawa Y-s, Ho M, Takayama S: High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. Analyst 2011;136:473-478.
65. Swietach P, Hulikova A, Patiar S, Vaughan-Jones RD, Harris AL: Importance of intracellular pH in determining the uptake and efficacy of the weakly basic chemotherapeutic drug, doxorubicin. PLoS One 2012;7:e35949.
66. Nam J-M, Onodera Y, Bissell MJ, Park CC: Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin a5b1 and fibronectin. Cancer Res 2010;70:5238-5248.
67. Michaylira CZ, Wong GS, Miller CG, et al.: Periostin, a cell adhesion molecule, facilitates invasion in the tumor microenvironment and annotates a novel tumor-invasive signature in esophageal cancer. Cancer Res 2010;70:5281-5292.
68. Kondo J, Endo H, Okuyama H, et al.: Retaining cell-cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer. Proc Natl Acad Sci USA 2011;108:6235-6240.
69. Praveen K, Streiner N, Vo M, Anderes K, Yokota K, Ikeya T: Evaluation of Cell-able spheroid culture system for culturing patient derived primary tumor cells. Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research. Cancer Res 2012;72(8 Suppl):5270 [Abstract].
70. Fiebig H: Oncotest. www.oncotest.com/id-3d-assays.html (last accessed on April 11, 2014).
71. Vinci M, Gowan S, Boxall F, et al.: Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol 2012;10:29.
72. Lai Y, Asthana A, Kisaalita WS: Biomarkers for simplifying HTS 3D cell culture platforms for drug discovery: the case for cytokines. Drug Discov Today 2011;16:293-297.
73. Albrecht C, Helmreich M, Tichy B, et al.: Impact of 3D-culture on the expression of differentiation markers and hormone receptors in growth plate chondrocytes as compared to articular chondrocytes. Int J Mol Med 2009;23:347-355.
74. Mishra DK, Sakamoto JH, Thrall MJ, et al.: Human lung cancer cells grown in an ex vivo 3D lung model produce matrix metalloproteinases not produced in 2D culture. PLoS One 2012;7:e45308.
75. Yamada KM, Cukierman E: Modeling tissue morphogenesis and cancer in 3D. Cell 2007;130:601-610.
76. Bohunicky B, Mousa SA: Biosensors: the new wave in cancer diagnosis. Nanotechnol Sci Appl 2010;4:1-10.
77. Lei KF, Wu MH, Hsu CW, Chen YD: Real-time and non-invasive impedimetric monitoring of cell proliferation and chemosensitivity in a perfusion 3D cell culture microfluidic chip. Biosens Bioelectron 2014;51:16-21.
78. Jeong SH, Lee DW, Kim S, Kim J, Ku B: A study of electrochemical biosensor for analysis of three-dimensional (3D) cell culture. Biosens Bioelectron 2012; 35:128-133.
79. Daus AW, Layer PG, Thielemann C: A spheroid-based biosensor for the label-free detection of drug-induced field potential alterations. Sensor Actuat B-Chem 2012;165:53-58.
80. Zhou L, Huang G, Wang S, et al.: Advances in cell-based biosensors using three-dimensional cell-encapsulating hydrogels. Biotechnol J 2011;6:1466-1476.
81. Wu M-H, Chang Y-H, Liu Y-T, et al.: Development of high throughput microfluidic cell culture chip for perfusion 3-dimensional cell culture-based chemosensitivity assay. Sensor Actuat B-Chem 2011;155:397-407.
82. Zhang X, Yang ST: High-throughput 3-D cell-based proliferation and cytotoxicity assays for drug screening and bioprocess development. J Biotechnol 2011; 151:186-193.
83. Ben-Yoav H, Melamed S, Freeman A, Shacham-Diamand Y, Belkin S: Whole-cell biochips for bio-sensing: integration of live cells and inanimate surfaces. Crit Rev Biotechnol 2011;31:337-353.
84. Ong S-M, Zhang C, Toh Y-C, et al.: A gel-free 3D microfluidic cell culture system. Biomaterials 2008;29:3237-3244.
85. Lin SP, Kyriakides TR, Chen JJ: On-line observation of cell growth in a three-dimensional matrix on surface-modified microelectrode arrays. Biomaterials 2009;30:3110-3117.
86. Tan W, Desai TA: Layer-by-layer microfluidics for biomimetic three-dimensional structures. Biomaterials 2004;25:1355-1364.
87. Kim MS, Yeon JH, Park JK: A microfluidic platform for 3-dimensional cell culture and cell-based assays. Biomed Microdevices 2007;9:25-34.
88. Kloss D, Kurz R, Jahnke HG, et al.: Microcavity array (MCA)-based biosensor chip for functional drug screening of 3D tissue models. Biosens Bioelectron 2008;23:1473-1480.
89. Thielecke H, Mack A, Robitzki A: A multicellular spheroid-based sensor for anti-cancer therapeutics. Biosens Bioelectron 2001;16:261-269.
90. Hildebrandt C, Buth H, Cho S, Impidjati, Thielecke H: Detection of the osteogenic differentiation of mesenchymal stem cells in 2D and 3D cultures by electrochemical impedance spectroscopy. J Biotechnol 2010;148:83-90.
91. Wang J, Wu C, Hu N, Zhou J, Du L, Wang P: Microfabricated electrochemical cell-based biosensors for analysis of living cells in vitro. Biosensors 2012;2: 127-170.
92. Ngoepe M, Choonara Y, Tyagi C, et al.: Integration of biosensors and drug delivery technologies for early detection and chronic management of illness. Sensors 2013;13:7680-7713.
93. Souiri M, Gammoudi I, Mora L, et al.: A novel 3-D nano-assembly bacteria based biosensor for enhanced detection of heavy metal pollutants. J Environ Sci Eng 2012;1:924-935.
94. Torisawa Y-s, Shiku H, Yasukawa T, Nishizawa M, Matsue T: Multi-channel 3-D cell culture device integrated on a silicon chip for anticancer drug sensitivity test. Biomaterials 2005;26:2165-2172.
95. Lei KF, Wu MH, Hsu CW: Electrical impendance determination of cancer cell viability in a 3-dimensional cell culture microfluidic chip. Int J Electrochem Sci 2012;7:12817-12828.
96. Banerjee P, Lenz D, Robinson JP, Rickus JL, Bhunia AK: A novel and simple cell-based detection system with a collagen-encapsulated B-lymphocyte cell line as a biosensor for rapid detection of pathogens and toxins. Lab Invest 2008; 88:196-206.
97. Nguyen TA, Yin TI, Reyes D, Urban GA: Microfluidic chip with integrated electrical cell-impedance sensing for monitoring single cancer cell migration in three-dimensional matrixes. Anal Chem 2013;85:11068-11076.